| Class # | Subject | Catalog # | Section | Title | Enrollment Cap | Wait List | Currently Enrolled | Seats Available |
|---|---|---|---|---|---|---|---|---|
| 10501 | PH TX | 270 | 001 | Common Medicines | 15 | 0 | 0 | 15 |
| 3355 | PH TX | 2700 | 001 | Common Medicines | 100 | 0 | 51 | 49 |
| 3274 | PH TX | 5121 | 001 | Biomedical Basis Dis | 62 | 0 | 62 | 0 |
| 3275 | PH TX | 5221 | 001 | Pharmacology II | 55 | 0 | 45 | 10 |
| 3356 | PH TX | 5990 | 001 | Special Problems | 50 | 0 | 0 | 50 |
| 13616 | PH TX | 6030 | 001 | Pharmacology | 100 | 0 | 105 | -5 |
| 3276 | PH TX | 6221 | 001 | Pharmacology II | 20 | 0 | 2 | 18 |
| 4617 | PH TX | 6680 | 001 | Statistical Methods | 20 | 0 | 10 | 10 |
| 3910 | PH TX | 6710 | 001 | Dev Biochem Tox | 25 | 0 | 4 | 21 |
| 12384 | PH TX | 6970 | 001 | Thesis Research-MS | 1 | 0 | 0 | 1 |
| 6571 | PH TX | 7114 | 001 | Prin Tox | 20 | 0 | 3 | 17 |
| 11552 | PH TX | 7270 | 001 | Neuropharmacology | 50 | 0 | 6 | 44 |
| 14283 | PH TX | 7620 | 001 | Analytical Tox | 10 | 0 | 2 | 8 |
| 11553 | PH TX | 7710 | 001 | Pharm Res Exp I | 25 | 0 | 0 | 25 |
| 11554 | PH TX | 7720 | 001 | Pharm Res Exp II | 25 | 0 | 0 | 25 |
| 3358 | PH TX | 7890 | 001 | Research Seminar | 25 | 0 | 4 | 21 |
| 5789 | PH TX | 7920 | 001 | Research Pharmacology | 5 | 0 | 0 | 5 |
| 6754 | PH TX | 7920 | 026 | Research Pharmacology | 5 | 0 | 0 | 5 |
| 6756 | PH TX | 7920 | 028 | Research Pharmacology | 5 | 0 | 0 | 5 |
| 6757 | PH TX | 7920 | 029 | Research Pharmacology | 5 | 0 | 0 | 5 |
| 6759 | PH TX | 7920 | 031 | Research Pharmacology | 5 | 0 | 0 | 5 |
| 3359 | PH TX | 7970 | 001 | Thesis Research-PhD | 25 | 0 | 0 | 25 |
| 6760 | PH TX | 7970 | 024 | Thesis Research-PhD | 5 | 0 | 0 | 5 |
| 6763 | PH TX | 7970 | 027 | Thesis Research-PhD | 5 | 0 | 0 | 5 |
| 6764 | PH TX | 7970 | 028 | Thesis Research-PhD | 5 | 0 | 1 | 4 |
| 6765 | PH TX | 7970 | 029 | Thesis Research-PhD | 5 | 0 | 0 | 5 |
| 3360 | PH TX | 7980 | 001 | Faculty Consult-PhD | 25 | 0 | 0 | 25 |
| 3361 | PH TX | 7990 | 001 | Cont Reg PhD | 25 | 0 | 0 | 25 |